Otonomy (NASDAQ:OTIC) reported quarterly losses of $(0.18) per share. This is a 5.26 percent increase over losses of $(0.19) per share from the same period last year.
Lucid Diagnostics Reports Publication Of Future Effective Foundational Local Coverage Determination By Medicare Administrative Contractor Noridian Healthcare Solutions
Lucid's CLIA laboratory, which performs its EsoGuard test, operates within Noridian's jurisdiction
Noridian's foundational LCD, to become effective May 28, 2023, closely aligns with the LCD
